Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study of sildenafil plus therapeutic hypothermia to treat neonatal hypoxic-ischemic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Hypoxic-Ischemic Encephalopathy | Phase 2 | Status: NOT_YET_RECRUITING